Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva
- PMID: 9708512
Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva
Abstract
In patients with early-stage squamous cell cancer of the vulva, inguinofemoral lymphadenectomy is performed primarily as a diagnostic procedure. The morbidity of this procedure, however, is not negligible. The aim of this study was to evaluate the feasibility of minimally invasive detection of the sentinel inguinofemoral lymph node (SILN) and to investigate whether the histopathology of the SILNs is representative of that of the other non-SILNs.
Methods: Patients with early-stage squamous cell cancer of the vulva, planned for resection of the primary tumor and uni- or bilateral inguinofemoral lymphadenectomy, were eligible for the study. Technetium-99m-labeled nanocolloid was injected intradermally at four locations around the tumor the day before operation. Images were recorded immediately and after 2.5 hr using a gamma camera. SILN locations were marked on the overlying groin skin. The next day, during general anesthesia, blue patent dye was injected intradermally at the same locations around the tumor. During the operation SILNs were identified at the place indicated using a handheld gamma-detection probe. It was noted if SILNs were found by the probe, by blue dye or by both techniques. After resection of the SILNs, a standard inguinofemoral lymphadenectomy was performed. The results of histopathology of the SILNs were compared with those of the non-SILNs.
Results: The procedure was well tolerated by 10 of 11 patients. One patient, initially agreeing to participate, refused the injection of tracer because of fear of pain. In all 10 patients, identification of the SILNs was successful. The mean time for identification was 11 min. Identification of SILNs was primarily performed using the hand probe in all patients, whereas in 10 of 18 removed SILNs afferent lymph channels were also blue stained (56%). In 8 patients, pathologic examination showed no metastatic disease in both SILNs and non-SILNs, whereas in 2 patients metastases in the SILNs (one and two metastatic lymph nodes, respectively), as well as in other non-SILNs, were found.
Conclusion: This study shows that identification of SILNs in squamous cell cancer of the vulva is feasible with preoperatively administered 99mTc-labeled nanocolloid. Intraoperatively administered blue dye was only useful for confirmation of identification with nanocolloid. To date, no false-negative SILNs have been found, but expansion of the study is necessary to determine the possible clinical application of this new diagnostic technique.
Similar articles
-
Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany.Gynecol Oncol. 2008 Nov;111(2):282-8. doi: 10.1016/j.ygyno.2008.08.007. Epub 2008 Sep 19. Gynecol Oncol. 2008. PMID: 18804850
-
Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study.Int J Gynecol Cancer. 2003 Mar-Apr;13(2):182-6. doi: 10.1046/j.1525-1438.2003.13003.x. Int J Gynecol Cancer. 2003. PMID: 12657121
-
Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva.Gynecol Oncol. 2003 Jun;89(3):475-9. doi: 10.1016/s0090-8258(03)00130-6. Gynecol Oncol. 2003. PMID: 12798714
-
[Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].Rev Esp Med Nucl. 1999;18(2):111-21. Rev Esp Med Nucl. 1999. PMID: 10352326 Review. Spanish.
-
Sentinel node mapping with radiotracer alone in vulvar cancer: a five year single-centre experience and literature review.Eur J Gynaecol Oncol. 2015;36(1):10-5. Eur J Gynaecol Oncol. 2015. PMID: 25872327 Review.
Cited by
-
Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging systems?Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1684-8. doi: 10.1007/s00259-003-1264-4. Epub 2003 Sep 11. Eur J Nucl Med Mol Imaging. 2003. PMID: 13680196 Review.
-
Melanoma & nuclear medicine: new insights & advances.Melanoma Manag. 2018 Jun 28;5(1):MMT06. doi: 10.2217/mmt-2017-0022. eCollection 2018 Jun. Melanoma Manag. 2018. PMID: 30190932 Free PMC article. Review.
-
The Impact of HPV as an Etiological Factor in Gynecological and Oropharyngeal Cancer.Am J Lifestyle Med. 2015 Feb 12;10(4):253-261. doi: 10.1177/1559827615569707. eCollection 2016 Jul-Aug. Am J Lifestyle Med. 2015. PMID: 30202280 Free PMC article.
-
Feasibility and Diagnostic Accuracy of Ultrastaging in the Detection of Micrometastases in Sentinel and Non-sentinel Lymph Nodes in Cervical Cancer: A Single-Center Retrospective Study With a Five-Year Follow-Up Period.Cureus. 2024 May 29;16(5):e61336. doi: 10.7759/cureus.61336. eCollection 2024 May. Cureus. 2024. PMID: 38947581 Free PMC article.
-
Sentinel node procedure in Ib cervical cancer: a preliminary series.Br J Cancer. 2001 Sep 14;85(6):791-4. doi: 10.1054/bjoc.2001.2005. Br J Cancer. 2001. PMID: 11556825 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical